Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul><li>Sinovac / In Depth: Sinovac’s Covid fortune fuels bitter boardroom battle</li><li>Wahaha /Chinese beverage heir was an American citizen, U.S. tax records reveal</li><li>Visa /U.S. visa scrutiny pushes Chinese students to scrub their social media</li></ul>

Sinovac / In Depth: Sinovac’s Covid fortune fuels bitter boardroom battleWahaha /Chinese beverage heir was an American citizen, U.S. tax records revealVisa /U.S. visa scrutiny pushes Chinese students to scrub their social media

CX Daily: Sinovac’s Covid Fortune Fuels Bitter Boardroom Battle 

United States

Sinovac Biotech Ltd. researches, develops, manufactures, and markets various vaccines, including flu 
vaccines and vaccines for Hepatitis A.  The Company's products are sold in the Peoples Republic 
of China and other countries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sinovac Biotech (SVA US)

CX Daily: Sinovac’s Covid Fortune Fuels Bitter Boardroom Battle

TOP STORIES Sinovac / In Depth: Sinovac’s Covid fortune fuels bitter boardroom battle The Covid-19 pandemic turned Chinese vaccine-maker Sinovac...

Caixin Global

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)